Frequency of non‐motor symptoms and their impact on the quality of life in patients with Parkinson's disease: a prospective descriptive case series

Abstract

Ignoring NMS while focusing primary on motor symptoms in IPD can cause serious insufficiencies in treatment plans. Assessing NMS and dopamine dysregulation syndrome with structured scales that employ an integrated approach can improve QOL in IPD.